|Automated subtyping of HIV-1 genetic sequences for clinical and surveillance purposes: performance evaluation of the new REGA version 3 and seven other tools|
AC Pineda-Peña, NR Faria, S Imbrechts, P Libin, AB Abecasis, ...
Infection, genetics and evolution 19, 337-348, 2013
|HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics|
AB Abecasis, AMJ Wensing, D Paraskevis, J Vercauteren, K Theys, ...
Retrovirology 10 (1), 1-13, 2013
|Recombination confounds the early evolutionary history of human immunodeficiency virus type 1: subtype G is a circulating recombinant form|
AB Abecasis, P Lemey, N Vidal, T de Oliveira, M Peeters, R Camacho, ...
Journal of virology 81 (16), 8543-8551, 2007
|Quantifying differences in the tempo of human immunodeficiency virus type 1 subtype evolution|
AB Abecasis, AM Vandamme, P Lemey
Journal of virology 83 (24), 12917-12924, 2009
|A genomic signature and the identification of new sporulation genes|
AB Abecasis, M Serrano, R Alves, L Quintais, JB Pereira-Leal, ...
Journal of bacteriology 195 (9), 2101-2115, 2013
|Phylogeography of dengue virus serotype 4, Brazil, 2010–2011|
MRT Nunes, NR Faria, HB Vasconcelos, DB de Almeida Medeiros, ...
Emerging infectious diseases 18 (11), 1858, 2012
|Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G|
AB Abecasis, K Deforche, J Snoeck, LT Bacheler, P McKenna, ...
Aids 19 (16), 1799-1806, 2005
|Investigation of baseline susceptibility to protease inhibitors in HIV-1 subtypes C, F, G and CRF02_AG|
AB Abecasis, K Deforche, LT Bacheler, P McKenna, AP Carvalho, ...
Antiviral therapy 11 (5), 581, 2006
|Phylodynamics of the HIV-1 CRF02_AG clade in Cameroon|
NR Faria, MA Suchard, A Abecasis, JD Sousa, N Ndembi, I Bonfim, ...
Infection, Genetics and Evolution 12 (2), 453-460, 2012
|Sampling bias and incorrect rooting make phylogenetic network tracing of SARS-COV-2 infections unreliable|
C Mavian, SK Pond, S Marini, BR Magalis, AM Vandamme, S Dellicour, ...
Proceedings of the National Academy of Sciences 117 (23), 12522-12523, 2020
|Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe|
D Frentz, DAMC Van de Vijver, AB Abecasis, J Albert, O Hamouda, ...
BMC infectious diseases 14 (1), 1-12, 2014
|HIV-1 subtype is an independent predictor of reverse transcriptase mutation K65R in HIV-1 patients treated with combination antiretroviral therapy including tenofovir|
K Theys, J Vercauteren, J Snoeck, M Zazzi, RJ Camacho, C Torti, ...
Antimicrobial agents and chemotherapy 57 (2), 1053-1056, 2013
|Patterns of transmitted HIV drug resistance in Europe vary by risk group|
D Frentz, D van de Vijver, A Abecasis, J Albert, O Hamouda, L Jørgensen, ...
PloS one 9 (4), e94495, 2014
|Limited cross-border infections in patients newly diagnosed with HIV in Europe|
D Frentz, AMJ Wensing, J Albert, D Paraskevis, AB Abecasis, O Hamouda, ...
Retrovirology 10 (1), 1-10, 2013
|HIV and tuberculosis co-infection among migrants in Europe: A systematic review on the prevalence, incidence and mortality|
AM Tavares, I Fronteira, I Couto, D Machado, M Viveiros, AB Abecasis, ...
PloS one 12 (9), e0185526, 2017
|Transmission of HIV-2.|
P Gomes, A Abecasis, M Almeida, R Camacho, K Mansinho
The Lancet. Infectious diseases 3 (11), 683-684, 2003
|Origin and epidemiological history of HIV-1 CRF14_BG|
I Bartolo, AB Abecasis, P Borrego, H Barroso, F McCutchan, P Gomes, ...
PLoS One 6 (9), e24130, 2011
|Science in court: the myth of HIV fingerprinting.|
AB Abecasis, AM Geretti, J Albert, L Power, M Weait, AM Vandamme
The Lancet. Infectious Diseases 11 (2), 78-79, 2011
|HIV-1 genetic diversity and transmitted drug resistance in health care settings in Maputo, Mozambique|
I Bártolo, J Casanovas, R Bastos, C Rocha, AB Abecasis, E Folgosa, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 51 (3), 323-331, 2009
|HIV-1 genetic variants circulation in the North of Angola|
A Abecasis, D Paraskevis, M Epalanga, M Fonseca, F Burity, ...
Infection, Genetics and Evolution 5 (3), 231-237, 2005